Cost-Effectiveness of Zoledronic Acid Versus Oral Alendronate for Postmenopausal Osteoporotic Women in China
ObjectiveThis study aims to estimate the cost-effectiveness of yearly intravenous zoledronic acid treatment versus weekly oral alendronate for postmenopausal osteoporotic women in China.MethodsWe used a Markov microsimulation model to compare the cost-effectiveness of zoledronic acid with alendronat...
Main Authors: | Ruxu You, Yu Zhang, David Bin-Chia Wu, Jinyu Liu, Xinyu Qian, Nan Luo, Takahiro Mori |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00456/full |
Similar Items
-
Alendronate improves QOL of postmenopausal women with osteoporosis
by: Hisaya Kawate, et al.
Published: (2010-04-01) -
Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide
by: Takahiro Mori, et al.
Published: (2019-11-01) -
Once-yearly zoledronic acid in hip fracture prevention
by: Oddom Demontiero, et al.
Published: (2009-03-01) -
REVIEW OF BASIC CLINICAL TRIALS OF ALENDRONATE
by: E G Zotkin, et al.
Published: (2010-03-01) -
Atypical femoral fracture in the setting of alendronate treatment for osteoporosis: a case report and literature review
by: Eric D. Van Baarsel, et al.
Published: (2019-07-01)